AGFA Gevaert slides to Q4, 2011 red
AGFA Gevaert (EBR:AGFB) swung to red ink for the 4th quarter and 2011.
The Belgian medical device maker posted losses of $56 million (€43 million) on sales of $1.04 billion (€805 million) for the 3 months ended Dec. 31, 2011.
That compares with profits of $41 million (€43 million) on sales of $1.04 billion (€806 million) during the same period in 2010.
For the full year, AGFA reported losses of $94.6 million (€73 million) on sales of $3.92 billion (€3.02 billion). That compares with profits of $136.1 million (€105 million) on sales of $3.82 billion (€2.95 billion). Read more
Amplifon’s 2011 sales, earnings rise
Amplifon (BIT:AMP) posted profits of $55.3 million (€42.7 million) on sales of $1.07 billion (€827.4 million) for the 12 months ended Dec. 31, 2011.
That compares with profits of $44.3 million (€34.2 million) on sales of $917.6 million (€708.1 million) during the same period in 2010. Read more
Analogic’s Q2 ultrasound sales climb 21%
Analogic’s (NSDQ:ALOG) ultrasound division reported sales of $41.1 million during the 3 months ended Jan. 31, up 20.9% compared with $34.0 million during the same period in 2010. Analogic’s medical imaging segment posted sales of $75.3 million, up 3.4% compared with $72.8 million during Q2 2011.
Overall, Analogic posted profits of $19.6 million, or $1.59 per diluted share, on sales of $126.4 million during Q2 2012. That compares with profits of $5.3 million, or 42 cents per diluted share, on sales of $117.3 million during the same period in 2010. Read more
Staar Surgical swings to Q4 black
Staar Surgical (NSDQ:STAA) posted profits of $109,000, or 0 cents per diluted share, on sales of $16.4 million for the 3 months ended Dec. 30, 2011.
That compares with losses of $691,000 million, or 2 cents per diluted share, on sales of $14.4 million during the same period in 2010.
For the full year, Staar logged profits of $1.3 million, or 4 cents per share, on sales of $62.8 million. That compares with profits of $53,000, or 0 cents per share, on sales of $55.0 million. Read more
Nordion puts up Q1 red ink
Nordion (NYSE:NDZ) posted losses of $887 million, or 1 cent per share, on sales of $53.0 million for the 3 months ended Jan. 31.
That compares with profits of $21.5 million, or 32 cents per share, on sales of $65.0 million during the same period in the prior year. Read more
Deltex narrows 2011 loss on flat sales
Deltex Medical Group (LON:DEMG) posted losses of $2.2 million (£1.4 million), or 2 cents per share (£0.01), on sales of $9.8 million (£6.3 million) for the 12 months ended Dec. 31, 2011.
That compares with losses of $2.3 million (£1.5 million), also 2 cents per share (£0.01), on sales of $9.7 million (£6.3 million) during the same period in 2010. Read more
